Current Cancer Centers Using the ChemoID Assay

​www.ahn.org/cancer-institute/brain-cancer/treatment

https://www.medscape.com/viewarticle/972276

https://www.mdedge.com/hematology-oncology/article/253824/cns/brain-cancer/assay-guided-chemo-recurrent-glioma-linked

https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-association-for-cancer-research-aacr/aacr-2022/high-grade-glioma-assay-guided-therapy-improves-survival/

www.pvhomed.com/new-technology-is-making-a-difference-in-the-fight-against-cancer/

www.uc.edu/news/articles/2019/01/n2062227.html

Recently Concluded Randomized Clinical Trials

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

  • University of Cincinnati Cancer Center, Cincinnati, OH
  • Stephenson Cancer Center, University of Oklahoma, OK
  • Allegheny Health Network, Pittsburgh, PA
  • Edwards Cancer Center, Huntington, WV
  • Arizona Oncology, Phoenix, Arizona
  • Charleston Area Medical Center, Charleston, WV
  • Kaiser Permanente, Los Angeles, California
  • Indiana University, Indianapolis, Indiana
  • Miami Cancer Institute, Miami, Florida

Standard chemotherapy versus chemotherapy chosen by cancer stem cell chemosensitivity testing in the management of patients with recurrent Glioblastoma Multiforme (GBM).

  • Allegheny Health Network, Pittsburgh, PA
  • Thomas Jefferson Hospital, Philadelphia
  • Penn State University Cancer Center, Hershey, PA
  • University of Cincinnati Brain Center, Cincinnati, OH
  • Charleston Area Medical Center, Charleston, WV
  • University of Toledo Medical Center, Toledo, OH
  • University of Mississippi Cancer Center, Jackson, MS
  • University of Maine, Scarborough, ME
  • Providence Cancer Center Oncology, Portland, Oregon
  • St. Luke’s University Health Network, Bethlehem, PA
  • Louisiana State University, New Orleans, LA
  • Kaiser Permanente, Los Angeles, CA
  • University of Southern California, Los Angeles, CA